Filing Flows › Altria Group (MO) › Q2 2026 › vs Q2 2025
Altria Group (MO) Q2 2026 vs Q2 2025 (year over year)
Altria Group's revenue rose $9.0M (+0.1%) from $6.1B in Q2 2025 to $6.1B in Q2 2026. The biggest changes: Oral Tobacco Segment −$40.0M (-5%); Smokeable Products Segment +$35.0M (+0.7%); All Other +$14.0M (—). Gross margin 62.5% against 63.1% (-0.6 pts).
Altria Group, Q2 2026: revenue $6.1B (+0.1% year over year), operating margin 51.3%, net earnings $2.3B, operating cash flow $719M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 62.5% | 63.1% | -0.6 pts |
| Operating margin | 51.3% | 52.9% | -1.6 pts |
| Net margin | 37.6% | 39.0% | -1.4 pts |
| Free cash flow margin | 10.8% | 2.8% | +8.0 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Smokeable Products Segment | $5.4B | $5.4B | $35.0M | +0.7% |
| Oral Tobacco Segment | $713M | $753M | −$40.0M | -5% |
| All Other | $6.0M | −$8.0M | $14.0M | — |
| Revenue | $6.1B | $6.1B | $9.0M | +0.1% |
| Gross profit | $3.8B | $3.9B | −$30.0M | -0.8% |
| Cost of revenue | $2.3B | $2.3B | $39.0M | +2% |
| Operating profit | $3.1B | $3.2B | −$94.0M | -3% |
| Operating expenses | $684M | $620M | $64.0M | +10% |
| Pre-tax earnings | $2.9B | $3.1B | −$189M | -6% |
| Other expense, net | $207M | $112M | $95.0M | +85% |
| Net earnings | $2.3B | $2.4B | −$80.0M | -3% |
| Income tax | $631M | $740M | −$109M | -15% |
| Depreciation & amortization | $56.0M | $71.0M | −$15.0M | -21% |
| Working capital & other | $1.6B | $2.2B | −$609M | -27% |
| Operating cash flow | $719M | $205M | $514M | +251% |
| Free cash flow (OCF − capex) | $662M | $173M | $489M | +283% |
| Capital expenditures | $57.0M | $32.0M | $25.0M | +78% |
Questions
How much did Altria Group's revenue grow year over year in Q2 2026?
Altria Group's revenue rose $9.0M (+0.1%) from $6.1B in Q2 2025 to $6.1B in Q2 2026.
What drove Altria Group's revenue change in Q2 2026?
Oral Tobacco Segment −$40.0M (-5%); Smokeable Products Segment +$35.0M (+0.7%); All Other +$14.0M (—).